Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Hepatology journal rankings 2024
30 ranked journals · Subfield in Medicine
Hepatology has 30 ranked journals in 2024. The median journal has an OJR of 0.73, below the world average of 1.00, up 0.03 on 2023; Q1 starts at OJR 1.29. The top three are Hepatology, Liver Cancer, and JHEP Reports.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Hepatology30
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
30 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1HepatologyLippincott Williams & Wilkins · United States | 4.48Q1 | 14.77 3.59 up from 2023 | 1,054 | 36% | $2,900 | ||
2Liver CancerOAKarger Publishers · Switzerland | 2.86Q1 | 8.15 1.41 down from 2023 | 186 | 100% | $3,590 | ||
3JHEP ReportsOAElsevier BV · Netherlands | 2.83Q1 | 7.56 1.41 down from 2023 | 481 | 100% | $4,110 | ||
4Journal of GastroenterologySpringer Science+Business Media · Japan | 2.48Q1 | 5.94 1.57 down from 2023 | 283 | 53% | $5,290 | ||
5Hepatology InternationalSpringer Science+Business Media · Switzerland | 1.91Q1 | 5.62 0.23 up from 2023 | 478 | 47% | $3,090 | ||
6Clinics in Liver DiseaseElsevier BV · United States | 1.70Q1 | 5.05 1.23 up from 2023 | 165 | 22% | $3,000 | ||
7Liver InternationalWiley · United Kingdom | 1.61Q1 | 4.53 0.72 down from 2023 | 956 | 70% | $4,780 | ||
8Journal of Hepatocellular CarcinomaOADove Medical Press · New Zealand | 1.29Q1 | 3.54 1.03 down from 2023 | 390 | 100% | $2,836 | ||
9World Journal of HepatologyOABaishideng Publishing Group · United States | 1.13Q2 | 2.89 0.21 down from 2023 | 443 | 100% | — | ||
10Hepatology ResearchWiley · Netherlands | 1.09Q2 | 3.32 0.61 down from 2023 | 347 | 56% | $3,400 | ||
11Hepatic Medicine Evidence and ResearchOADove Medical Press · New Zealand | 1.05Q2 | 2.14 1.54 down from 2023 | 50 | 100% | $2,320 | ||
12Canadian Journal of Gastroenterology and HepatologyOAPulsus Group · United Kingdom | 0.94Q2 | 2.54 0.56 down from 2023 | 230 | 100% | $2,830 | ||
13Clinical Liver DiseaseLippincott Williams & Wilkins · United States | 0.92Q2 | 1.53 1.80 down from 2023 | 328 | 100% | — | ||
14Journal of Clinical and Experimental HepatologyElsevier BV · India | 0.92Q2 | 2.71 0.17 down from 2023 | 476 | 29% | $3,150 | ||
15HepatoBiliary Surgery and NutritionOAAME Publishing Company · Hong Kong SAR China | 0.77Q2 | 1.91 0.04 down from 2023 | 446 | 100% | — | ||
16Clinics and Research in Hepatology and GastroenterologyElsevier BV · Netherlands | 0.69Q3 | 1.90 0.27 down from 2023 | 543 | 27% | $3,260 | ||
17Clinical and Experimental HepatologyOAPoland | 0.65Q3 | 2.01 0.17 up from 2023 | 146 | 100% | — | ||
18International Journal of HepatologyOAHindawi Publishing Corporation · United Kingdom | 0.64Q3 | 1.70 0.03 down from 2023 | 30 | 100% | $1,000 | ||
19European Journal of Gastroenterology & HepatologyLippincott Williams & Wilkins · United States | 0.59Q3 | 1.79 0.19 down from 2023 | 650 | 26% | — | ||
20Journal of interventional medicineOAElsevier BV · China | 0.54Q3 | 1.33 0.08 up from 2023 | 106 | 100% | $980 | ||
21Portal hypertension & cirrhosisOAPublisher not listed | 0.50Q3 | 1.45 0.34 up from 2023 | 58 | 100% | $0 listed | ||
22iLiverOAElsevier BV · United Kingdom | 0.47Q3 | 1.48 0.55 up from 2023 | 73 | 100% | $1,600 | ||
23Case Reports in HepatologyOAHindawi Publishing Corporation · United Kingdom | 0.43Q3 | 0.92 0.21 down from 2023 | 36 | 100% | $790 | ||
24Current Hepatology ReportsSpringer Science+Business Media · United States | 0.42Q4 | 1.29 0.29 up from 2023 | 65 | 28% | $3,990 | ||
25Hepatoma ResearchOAUnited States | 0.39Q4 | 1.18 0.41 down from 2023 | 170 | 100% | — | ||
26Canadian Liver JournalUniversity of Toronto Press · Canada | 0.37Q4 | 0.98 0.11 up from 2023 | 99 | 100% | — | ||
27Liver Cancer InternationalOAWiley · United States | 0.27Q4 | 0.68 0.03 down from 2023 | 41 | — | $2,200 | ||
28GastroHepOAWiley · United Kingdom | 0.25Q4 | 0.86 0.20 up from 2023 | 78 | 100% | $840 | ||
29Digestive Disease InterventionsGeorg Thieme Verlag · United States | 0.07Q4 | 0.13 0.08 down from 2023 | 128 | 5% | — | ||
30The Open Biomarkers JournalOABentham Science Publishers · Netherlands | 0.03Q4 | 0.07 0.18 down from 2023 | 31 | 100% | — |
Subfields of Medicine, with Hepatology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
6 additional Hepatology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 30
- Window papers (baseline)
- 31,100 -0.2% from indicator year 2021
- Median OJR
- 0.73 -33.7% from indicator year 2021
- Rising journals (2025)
- 2
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 7 | 7 | 7 | 7 | 7 | 9 | 9 | 8 | 9 | 10 | 10 | 12 | 16 | 18 | 18 | 19 | 21 | 23 | 24 | 23 | 26 | 29 | 28 | 32 | 30 | 28 | |
| Window papers (baseline) | 10,938 | 11,915 | 12,721 | 13,596 | 14,144 | 15,628 | 17,377 | 19,094 | 20,215 | 21,244 | 22,228 | 23,484 | 24,603 | 26,111 | 27,770 | 29,460 | 30,678 | 31,019 | 31,011 | 30,818 | 30,856 | 31,165 | 31,691 | 31,561 | 31,100 | 30,612 | |
| Median OJR | 0.59 | 0.58 | 0.72 | 0.99 | 0.957 | 0.83 | 0.929 | 1.041 | 1.099 | 0.907 | 1.09 | 0.930 | 0.88 | 1.02 | 0.81 | 0.8588 | 0.908 | 1.039 | 0.8591 | 0.87 | 0.959 | 1.103 | 0.75 | 0.71 | 0.73 | 0.67 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.